GSTM2 and cancer: All the promoter regions for which we demonstrated cancer-linked hypermethylation by pyrosequencing (BRCA1, CD44, GSTM2, GSTP1, MSI1, NFE2L3, RASSF1, RUNX3 and SIX3) exhibited an inverse correlation with expression among the cancers.